Objective To observe the clinical effect of pulmonary encephalopathy treated with lung-brain composition. Methods 82 cases of pulmonary encephalopathy were randomly divided 42 as treatment group and 40 as control group. Both two groups treated with regular treatments as anti-infection, persistent oxygen uptakei intravenous infusions of naloxone. Lung-brain composition were applied in the treatment group (lobeline 3mg×3 + Coramine 0. 375g×3 + aminophylline 0.125g+ dexamethasone 10mg in 5% glucose injection (250mL), iv, ql2h). Observe clinical effects of the two groups after 7-day treatment. Results The clinical effective rate of treatment group was 92. 8% which was higher than 75% in control group, the difference was statistically significant (P<0. 05). Conclusion The addition of lung-brain composition is effective than regular treatments in pulmonary encephalopathy.%目的 观察肺脑合剂治疗肺性脑病的临床疗效.方法 将82例肺性脑病患者,随机分为治疗组42例,对照组40例,两组患者均给予抗感染、低流量吸氧以及静脉滴注纳洛酮等常规治疗,治疗组在此基础上加用肺脑合剂治疗(洛贝林3mg×3支、可拉明0.375g×3支、氨茶碱0.125g、地塞米松10mg加入5％葡糖糖液250ml中静脉滴注,每12h1 次).两组均治疗7天后观察疗效,并进行比较.结果 治疗组总有效率为92.8％,对照组为75％,治疗组疗效显著优于对照组(P＜0.05).结论 加用肺脑合剂治疗肺性脑病的临床疗效比常规治疗效果更好,可在临床推广应用.
展开▼
